In-depth Analysis of Immunopeptidomics: From Sample Preparation to Data Analysis

Immunopeptidomics is a rapidly evolving frontier technology focusing on the identification and analysis of antigenic peptides presented by Major Histocompatibility Complex (MHC). This technology shows great potential in tumor immunotherapy, vaccine development, and autoimmune disease research.

1. What is Immunopeptidomics and Why is it Important?

Immunopeptidomics is an approach that utilizes high-resolution mass spectrometry to analyze peptides (immunopeptides) presented by MHC molecules. These peptides reflect the true state of intracellular protein degradation and are key clues for T cells to recognize abnormal cells, such as cancer or infected cells.

The technical challenges of immunopeptidomics are greater, but its biological significance is more direct:

• Precisely identify potential antigens for designing cancer vaccines or personalized immunotherapies;

• Reveal tumor immune evasion mechanisms;

• Monitor immune therapy responses and resistance mechanisms.

2. Sample Preparation: The First Step to Success

Sample preparation in immunopeptidomics is crucial because the abundance of MHC-bound peptides is extremely low and they are prone to degradation. A stable and reproducible sample processing workflow is the foundation for subsequent data reliability.

1. Cell Lysis and MHC Immunoprecipitation

Immunoprecipitation (IP) using monoclonal antibodies against MHC-I or MHC-II is a standard procedure. It typically requires:

• Large amounts of cell or tissue samples (>10^7 cells);

• Cold chain operations to prevent protein degradation;

• Optimized lysis buffer to ensure complete extraction of MHC complexes.

2. Peptide Release and Purification

Peptides released from MHC complexes need further separation and purification. Common methods for this step include:

• Acid elution methods (e.g., 0.1% TFA) to release bound peptides;

• C18 solid-phase extraction columns to enrich peptides and remove impurities and large molecular proteins;

• Lyophilization concentration for subsequent mass spectrometry loading.

3. Mass Spectrometry Analysis: Core Technology for Antigen Mapping

Immunopeptides are short (8–14 amino acids) and lack cleavage sites, posing higher demands on mass spectrometry.

1. Instrument Selection: High Resolution is Key

It is recommended to use high-resolution mass spectrometry systems like Orbitrap Fusion Lumos and Exploris 480, paired with nano-LC systems for high sensitivity detection of low-abundance peptides.

2. Data Acquisition Methods: DDA vs. DIA

• DDA (Data Dependent Acquisition): Suitable for discovering new antigens, and data quality control is easy;

• DIA (Data Independent Acquisition): Suitable for quantitative analysis of known antigen databases, with better reproducibility.

4. Data Analysis: From Peptides to Biological Interpretation

The data analysis workflow in immunopeptidomics requires proteomics algorithms and specialized design for MHC binding characteristics.

1. Peptide Identification

Software like PEAKS, MaxQuant, and MSFragger can be used for non-specific enzyme searches, with the following parameters set:

• No enzyme cleavage restrictions;

• Common modifications such as oxidation and deamidation;

• Precise parent ion and fragment mass tolerance (<10 ppm).

2. MHC Binding Prediction and Epitope Annotation

Identified peptides are input into tools like NetMHCpan and MHCflurry to predict their binding ability to specific HLA alleles.

This step can be used for:

• New antigen screening;

• Vaccine candidate peptide screening;

• Formulating personalized immunotherapy strategies.

3. Downstream Functional Annotation

Integrate protein annotation databases (e.g., Uniprot, GO, KEGG) to achieve functional annotation of source proteins, pathway enrichment analysis, etc., providing biological interpretation for antigen discovery.

5. Challenges and Future Trends

Although immunopeptidomics has been applied in several frontier fields, it still faces numerous challenges:

• Detection sensitivity limitations for low-abundance peptides;

• Complexity of MHC alleles;

• Comparability issues across individual samples.

Future research will focus more on:

• Immunopeptide analysis at single-cell levels;

• Multi-omics integration with spatial transcriptomics and immune repertoire data;

• AI-assisted antigen prediction and target selection.

Immunopeptidomics is reshaping our understanding of antigen presentation and immune recognition. In this complex yet promising field, the acquisition of high-quality data and precise bioinformatics analysis are indispensable. As a leading mass spectrometry and proteomics service provider in China, Biotech Pack Biosciences has established a comprehensive immunopeptidomics technology platform, covering the entire process from sample preparation, MHC enrichment, mass spectrometry detection to bioinformatics analysis. We serve multiple national key projects and innovative pharmaceutical companies, helping clients efficiently identify immune-related targets and accelerate the development of vaccines and cell therapies.